Health
Researchers report on novel SARS-CoV-2 Israeli strain with unique spike glycoprotein – News-Medical.Net
Researchers from Israel describe a novel SARS-CoV-2 strain with a non-synonymous mutation in its spike glycoprotein, designated as P681H; nevertheless, its emergence…
In a recent medRxiv* preprint report, a research group from Israel described a novel SARS-CoV-2 strain with a non-synonymous mutation in its spike glycoprotein, designated as P681H; nevertheless, its emergence has not been associated with increased infections rate, facilitated spread or vaccine evasion.
The coronavirus disease 2019 (COVID-19) is still running rampant all over the world. As of March 2021, Israel found itself amidst the third wave of the infection. This resulted in tightening the…
-
Business19 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business24 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business16 hours agoDicker Data rides the AI trend to double digit growth
-
Business19 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy